MilliporeSigma's Curiosity Cube Reaches Mid-Tour Milestone, Igniting STEM Passion in Thousands of Students

August 21, 2024 12:15 PM

NORTHAMPTON, MA / ACCESSWIRE / August 21, 2024 / After making stops in Laramie, Wyoming and Gernsheim, Germany, the 2024 Curiosity Cube tours in North America and Europe conducted by the Life Science business of Merck KGaA, Darmstadt, Germany, officially hit their halfway point. Running from February through November this year, the Curiosity Cube has ignited a passion for science with students at 120 events across 95 communities in North America...

Read more

Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

August 21, 2024 10:20 AM

CHICAGO, IL / ACCESSWIRE / August 21, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today, pursuant to its agreement with Virax Biolabs (NASDAQ: VRAX), that it...

Read more

Positive Interim Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study

August 21, 2024 9:00 AM

KELOWNA, BC / ACCESSWIRE / August 21, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received 4-week and 8-week blood glucose results from ongoing animal study WEIGHT-A24-1 (the "Study").DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A & B) were the top performers in the Study at day 56, with blood...

Read more

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

August 21, 2024 8:45 AM

BOULDER, CO / ACCESSWIRE / August 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it has entered into a distribution agreement with a leading...

Read more

Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025

August 21, 2024 8:15 AM

The Company shows continued progress towards cash-flow break even and profitabilityRecurring Technology Fee (SaaS) revenue - over 94% of total revenue with a 76% gross margin, which rose over 400 basis points and is expected to continue to trend higherGross margins improved significantly to 73.8 from 63.5% in the same period last year, and 59.6% 2 years earlierReduced SG&A to $3 million, down 16% compared to same period last yearOperating loss...

Read more

Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug

August 21, 2024 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation-activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it's lead drug formulation, Rutherrin® has been proven preclinically to be activated by Metformin, a common diabetes...

Read more

Encision Signs Master Services Agreement with Vicarious Surgical Inc.

August 21, 2024 6:00 AM

Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray energy burns in minimally invasive surgery, today announced that Encision has signed a Master Services Agreement ("Agreement") with Vicarious Surgical Inc. ("Vicarious").The Agreement commenced July 8, 2024 and will continue thereafter until terminated by certain actions of either party. Vicarious...

Read more

RFID Blood Monitoring Systems Market Is Expected to Reach USD 625.3 Million by 2034 And Grow at A Compound Annual Growth Rate of 6.30% | FMI Inc.

August 21, 2024 3:30 AM

The global RFID blood monitoring systems market is on a robust growth trajectory, with estimates projecting its value to soar from USD 127.4 million in 2024 to an impressive USD 234.7 million by 2034. This anticipated growth reflects a compound annual growth rate (CAGR) of 6.30% over the forecast period.In 2023, the revenue generated by RFID blood monitoring systems stood at USD 119.8 million. The market is expected to exhibit a year-over-year...

Read more

iZafe Group Secures Loan of SEK 5.5 million and Cancels Previously Issued Warrants of Series TO14B

August 21, 2024 3:30 AM

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE....

Read more

Spago Nanomedical Interim Report January-June 2024

August 21, 2024 2:20 AM

LUND, SE / ACCESSWIRE / August 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Clinical and non-clinical progress in the Tumorad program APRIL - JUNE IN BRIEFNet sales for the quarter amounted to KSEK 459 (KSEK 114)The loss for the quarter amounted to KSEK -8,152 (KSEK -9,449)Operating expenses for the quarter amounted to KSEK -10,255 (KSEK -10,982)Earnings per share, before and after dilution, for the quarter amounted to SEK -0.03 (SEK...

Read more

Andrew Klein, M.D. named UNOS Chief Medical Officer

August 20, 2024 4:30 PM

The United Network for Organ Sharing (UNOS) announced today that it selected Andrew S. Klein M.D., M.B.A., F.A.C.S. as Chief Medical Officer."Dr. Klein has long been one of the most respected transplant surgeons and clinical researchers in the country," said UNOS CEO Maureen McBride. United Network for Organ Sharing (UNOS) welcomes Andrew S. Klein, M.D. as its Chief Medical Officer. As Chief Medical Officer, Dr. Klein will serve as an expert...

Read more

Prism Clinical Imaging and Sora Neuroscience Announce Cooperation Agreement

August 20, 2024 1:00 PM

Prism Clinical Imaging, Inc. (Prism), experts in brain mapping software and applications, and Sora Neuroscience, Inc. (Sora), a brain imaging technology company, today announced a letter of cooperation to assist one another in performing validation testing and commercialization of products for brain resting state functional MRI (rs-fMRI) analysis.Sora Neuroscience is licensee of a portfolio of resting state network mapping technology developed...

Read more

Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023

August 20, 2024 12:20 PM

CHICAGO, IL / ACCESSWIRE / August 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the second quarter ended June 30, 2024.Second Quarter...

Read more

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award

August 20, 2024 10:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Eduardo Zimmer, Ph.D., a key collaborator with Magdalena Biosciences ("Magdalena"), the joint venture formed by Jaguar and Filament Health Corp. (OTCQB:FLHLF)(CBOE CA:FH)(FSE:7QS) to develop novel, natural prescription psychoactive medicines derived from plants for mental health indications, is the 2024 recipient of the prestigious Blas Frangione Early Career Achievement Award....

Read more

Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press

August 20, 2024 9:30 AM

LAS VEGAS, NV / ACCESSWIRE / August 20, 2024 / Hypha Labs, Inc. (OTC PINK:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company's proprietary bioreactor which allows individuals and companies to produce specialized mushroom ingredients such as psilcybin, has been nominated as "Best New Product of 2024" by the Santa Monica Daily Press (SMDP).Hypha Bioreactor The Hypha Bioreactor which produces mushroom...

Read more

Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells

August 20, 2024 9:15 AM

ALLEN, TX / ACCESSWIRE / August 20, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that a study conducted at the Ministry of Health National Centre of Infectious and Parasitic Diseases in Sofia, Bulgaria concluded that inventor Harry Zhabilov's patented experimental cancer lyophilized pepsin treatment, exclusively licensed to Enzolytics, is effective in decreasing the growth and spread of cancer cells...

Read more

Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit

August 20, 2024 9:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the first quarter ended March 31, 2024.First Quarter 2024 Financial HighlightsIncome...

Read more

Gilead Sciences: "One of Best Employers for Women" by Forbes

August 20, 2024 9:00 AM

NORTHAMPTON, MA / ACCESSWIRE / August 20, 2024 / For the third year in a row, Forbes has recognized Gilead as one of America's Best Employers For Women. At Gilead, we champion a culture where women can make a direct and meaningful impact and we offer an inclusive workplace and competitive benefits centered around wellbeing. Together, we drive innovation and further our mission to create a healthier world for all people.About Gilead...

Read more

Oceanside Animal Hospital Partners With Local Rescues to Save Lives

August 20, 2024 9:00 AM

Together for a Cause: Animal Surgical Center's Devotion to Saving the Lives of Animals Through Compassionate Rescue CollaborationsOCEANSIDE, NY / ACCESSWIRE / August 20, 2024 / Through ongoing collaborations with multiple rescue groups, Animal Surgical Center continues to make a significant difference in the lives of animals in need. Help Save Animal Lives The mission is to save as many animals as possible. Animal Surgical Center's partnership...

Read more

MediLedger Partners With Prisma Health to Help Health System Enhance Pricing Accuracy and Contract Management

August 20, 2024 9:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 20, 2024 / The MediLedger network is excited to announce its partnership with Prisma Health, South Carolina's largest health organization. Prisma Health will be leveraging MediLedger's advanced technology to revolutionize contract management and ensure accurate pricing across its extensive network. Prisma Health joins other leading health systems, including OSF HealthCare and Baptist Health, on the...

Read more